1. Mori Y, Wada H, Okugawa Y, et al. Increased plasma thrombomodulin as a vascular endothelial cell marker in patients with thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Clin Appl Thromb Hemost2001;7:5-5.
2.
2. Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodulin in health and diseases. Blood1990;76:2024-2024.
3.
3. Akiyama K, Nakamura K, Makino I. Evaluation of plasma thrombomodulin (TM) levels in patients with liver disease. Nippon Shokakibyo Gakkai Zasshi1992;89:2559-2559.
4.
4. Zeniya M, Fukata H, Toda G. Thrombomodulin expression of sinusoidal endothelial cells in chronic viral hepatitis. J Gastroenterol Hepatol1995;10(suppl 1):77-77.
5.
5. Takatori M, Iwabuchi S, Ro S, et al. Increased serum levels and sinusoidal expression of thrombomodulin in acute liver damage. Thromb Res1999;93:113-113.
6.
6. Borawski J, Naumnik B, Pawlak K, My'liwiec M. Soluble thrombomodulin is associated with viral hepatitis, blood pressure, and medications in haemodialysis patients. Nephrol Dial Transplant2001;16:787-787.
7.
7. Suehiro T, Boros P, Sheiner P, et al. Effluent levels of thrombomodulin predict early graft function in clinical liver transplantation. Liver1997;17:224-224.
8.
8. Himmelreich G, Riewald M, Rosch R, et al. Thrombomodulin: A marker for endothelial damage during orthoptic liver transplantation. Am J Hematol1994;47:1-1.
9.
9. Eng HL, Chen YS, Jawan B, et al. Soluble thrombomodulin antigen as a marker for endothelial damage during liver transplantation. Transplant Proc2000;32:2273-2273.
10.
10. Kumada T, Dittman WA, Majerus PW. A role for thrombomodulin in the pathogenesis of thrombin-induced thromboembolism in mice. Blood1988;71:728-728.
11.
11. Hergesell O, Andrassy K, Geberth S, et al. Plasma thrombomodulin levels are dependent on renal function. Thromb Res1993;72:455-455.
12.
12. Mezzano D, Tagle R, Pais E, et al. Endothelial cell markers in chronic uremia: Relationship with hemostatic defects and severity of renal failure. Thromb Res1997;88:465-465.
13.
13. Naumnik B, Borawski J, Pawlak K, Mygliwiec M. Renal function, proteinuria and ACE-inhibitor therapy as determinants of plasma levels of endothelial markers. Nephrol Dial Transplant (in press).
14.
14. Dhainaut JF, Marin N, Mignon A, Vinsonneau C. Hepatic response to sepsis: Interaction between coagulation and inflammatory processes. Crit Care Med2001;29(suppl 7):42-42.
